• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂肪酸和内毒素激活小鼠肝细胞中的炎性体,释放危险信号以刺激免疫细胞。

Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells.

机构信息

Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA.

出版信息

Hepatology. 2011 Jul;54(1):133-44. doi: 10.1002/hep.24341.

DOI:10.1002/hep.24341
PMID:21488066
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4158408/
Abstract

UNLABELLED

The pathogenesis of nonalcoholic steatohepatitis (NASH) and inflammasome activation involves sequential hits. The inflammasome, which cleaves pro-interleukin-1β (pro-IL-1β) into secreted IL-1β, is induced by endogenous and exogenous danger signals. Lipopolysaccharide (LPS), a toll-like receptor 4 ligand, plays a role in NASH and also activates the inflammasome. In this study, we hypothesized that the inflammasome is activated in NASH by multiple hits involving endogenous and exogenous danger signals. Using mouse models of methionine choline-deficient (MCD) diet-induced NASH and high-fat diet-induced NASH, we found up-regulation of the inflammasome [including NACHT, LRR, and PYD domains-containing protein 3 (NALP3; cryopyrin), apoptosis-associated speck-like CARD-domain containing protein, pannexin-1, and pro-caspase-1] at the messenger RNA (mRNA) level increased caspase-1 activity, and mature IL-1β protein levels in mice with steatohepatitis in comparison with control livers. There was no inflammasome activation in mice with only steatosis. The MCD diet sensitized mice to LPS-induced increases in NALP3, pannexin-1, IL-1β mRNA, and mature IL-1β protein levels in the liver. We demonstrate for the first time that inflammasome activation occurs in isolated hepatocytes in steatohepatitis. Our novel data show that the saturated fatty acid (FA) palmitic acid (PA) activates the inflammasome and induces sensitization to LPS-induced IL-1β release in hepatocytes. Furthermore, PA triggers the release of danger signals from hepatocytes in a caspase-dependent manner. These hepatocyte-derived danger signals, in turn, activate inflammasome, IL-1β, and tumor necrosis factor α release in liver mononuclear cells.

CONCLUSION

Our novel findings indicate that saturated FAs represent an endogenous danger in the form of a first hit, up-regulate the inflammasome in NASH, and induce sensitization to a second hit with LPS for IL-β release in hepatocytes. Furthermore, hepatocytes exposed to saturated FAs release danger signals that trigger inflammasome activation in immune cells. Thus, hepatocytes play a key role in orchestrating tissue responses to danger signals in NASH.

摘要

非酒精性脂肪性肝炎(NASH)的发病机制和炎性小体激活涉及连续打击。炎性小体通过内源性和外源性危险信号将前白细胞介素-1β(pro-IL-1β)切割成分泌型白细胞介素-1β(IL-1β),并被其诱导。脂多糖(LPS)是一种 Toll 样受体 4 配体,在 NASH 中起作用,也可激活炎性小体。在这项研究中,我们假设炎性小体通过涉及内源性和外源性危险信号的多种打击在 NASH 中被激活。我们使用蛋氨酸胆碱缺乏(MCD)饮食诱导的 NASH 模型和高脂肪饮食诱导的 NASH 模型,发现炎性小体[包括 NACHT、LRR 和 PYD 结构域包含蛋白 3(NALP3;冷诱导 RNA 结合蛋白)、凋亡相关斑点样含 CARD 结构域蛋白、连接蛋白-1 和前胱天蛋白酶-1]的信使 RNA(mRNA)水平上调,caspase-1 活性增加,以及成熟的白细胞介素-1β(IL-1β)蛋白水平在患有脂肪性肝炎的小鼠中与对照肝脏相比有所增加。仅患有脂肪变性的小鼠中没有炎性小体激活。MCD 饮食使小鼠对 LPS 诱导的 NALP3、连接蛋白-1、IL-1βmRNA 和成熟 IL-1β蛋白水平在肝脏中的增加敏感。我们首次证明炎性小体激活发生在脂肪性肝炎的分离肝细胞中。我们的新数据表明,饱和脂肪酸(FA)棕榈酸(PA)激活炎性小体,并诱导肝细胞对 LPS 诱导的 IL-1β释放产生敏感性。此外,PA 以胱天蛋白酶依赖性方式从肝细胞中释放危险信号。这些来自肝细胞的危险信号反过来又在肝单核细胞中激活炎性小体、IL-1β和肿瘤坏死因子-α的释放。

结论

我们的新发现表明,饱和 FAs 以第一击的形式代表内源性危险,上调 NASH 中的炎性小体,并诱导对 LPS 诱导的 IL-β释放的敏感性增加。此外,暴露于饱和 FAs 的肝细胞释放危险信号,触发免疫细胞中的炎性小体激活。因此,肝细胞在协调 NASH 中组织对危险信号的反应中起关键作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdcc/4158408/c1b0b7698240/nihms620875f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdcc/4158408/0c7ca0505abb/nihms620875f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdcc/4158408/5d392deb459c/nihms620875f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdcc/4158408/12b806638445/nihms620875f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdcc/4158408/cd5880240069/nihms620875f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdcc/4158408/c1f97e420a68/nihms620875f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdcc/4158408/f769b40452e5/nihms620875f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdcc/4158408/4713fdf34892/nihms620875f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdcc/4158408/c1b0b7698240/nihms620875f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdcc/4158408/0c7ca0505abb/nihms620875f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdcc/4158408/5d392deb459c/nihms620875f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdcc/4158408/12b806638445/nihms620875f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdcc/4158408/cd5880240069/nihms620875f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdcc/4158408/c1f97e420a68/nihms620875f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdcc/4158408/f769b40452e5/nihms620875f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdcc/4158408/4713fdf34892/nihms620875f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdcc/4158408/c1b0b7698240/nihms620875f8.jpg

相似文献

1
Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells.脂肪酸和内毒素激活小鼠肝细胞中的炎性体,释放危险信号以刺激免疫细胞。
Hepatology. 2011 Jul;54(1):133-44. doi: 10.1002/hep.24341.
2
Dietary saturated fatty acid and polyunsaturated fatty acid oppositely affect hepatic NOD-like receptor protein 3 inflammasome through regulating nuclear factor-kappa B activation.膳食饱和脂肪酸和多不饱和脂肪酸通过调节核因子-κB激活对肝脏NOD样受体蛋白3炎性小体产生相反影响。
World J Gastroenterol. 2016 Feb 28;22(8):2533-44. doi: 10.3748/wjg.v22.i8.2533.
3
Both bone marrow-derived and non-bone marrow-derived cells contribute to AIM2 and NLRP3 inflammasome activation in a MyD88-dependent manner in dietary steatohepatitis.在饮食性脂肪性肝炎中,骨髓来源和非骨髓来源的细胞均以MyD88依赖的方式促进AIM2和NLRP3炎性小体的激活。
Liver Int. 2014 Oct;34(9):1402-13. doi: 10.1111/liv.12537. Epub 2014 Apr 17.
4
Cathepsin B inhibition ameliorates the non-alcoholic steatohepatitis through suppressing caspase-1 activation.组织蛋白酶 B 抑制通过抑制半胱氨酸天冬氨酸蛋白酶-1 的激活改善非酒精性脂肪性肝炎。
J Physiol Biochem. 2018 Nov;74(4):503-510. doi: 10.1007/s13105-018-0644-y. Epub 2018 Jul 17.
5
Inhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease development.硫氧还蛋白相互作用蛋白对小鼠库普弗细胞中NLRP3炎性小体的抑制作用作为非酒精性脂肪性肝病发展的一种调节机制。
Oncotarget. 2017 Jun 6;8(23):37657-37672. doi: 10.18632/oncotarget.17489.
6
Sweroside Prevents Non-Alcoholic Steatohepatitis by Suppressing Activation of the NLRP3 Inflammasome.山奈酚通过抑制 NLRP3 炎性小体的激活预防非酒精性脂肪性肝炎。
Int J Mol Sci. 2020 Apr 17;21(8):2790. doi: 10.3390/ijms21082790.
7
Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis.肝细胞焦亡和炎性小体颗粒的释放诱导肝星状细胞活化和肝纤维化。
J Hepatol. 2021 Jan;74(1):156-167. doi: 10.1016/j.jhep.2020.07.041. Epub 2020 Aug 4.
8
CXCL5 promotes lipotoxicity of hepatocytes through upregulating NLRP3/Caspase-1/IL-1β signaling in Kupffer cells and exacerbates nonalcoholic steatohepatitis in mice.CXCL5 通过上调库普弗细胞中 NLRP3/Caspase-1/IL-1β 信号通路促进肝细胞脂肪毒性,并在小鼠中加剧非酒精性脂肪性肝炎。
Int Immunopharmacol. 2023 Oct;123:110752. doi: 10.1016/j.intimp.2023.110752. Epub 2023 Aug 11.
9
Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis.Caspase-1 介导体脂性肝炎中纤维化的形成。
Lab Invest. 2012 May;92(5):713-23. doi: 10.1038/labinvest.2012.45. Epub 2012 Mar 12.
10
Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice.Toll 样受体 2 和软脂酸通过炎症小体激活协同促进小鼠非酒精性脂肪性肝炎的发生。
Hepatology. 2013 Feb;57(2):577-89. doi: 10.1002/hep.26081.

引用本文的文献

1
Inflammatory and metabolic markers mediate the association between urinary metals and non-alcoholic fatty liver disease in U.S. adults: a cross-sectional study.炎症和代谢标志物介导美国成年人尿金属与非酒精性脂肪性肝病之间的关联:一项横断面研究。
Front Public Health. 2025 Jul 4;13:1564302. doi: 10.3389/fpubh.2025.1564302. eCollection 2025.
2
TREM2 in MASH: integrating lipid metabolism and immune response.MASH中的TREM2:整合脂质代谢与免疫反应
Front Immunol. 2025 Jun 25;16:1604837. doi: 10.3389/fimmu.2025.1604837. eCollection 2025.
3
Gut microbiome in metabolic dysfunction-associated steatotic liver disease and associated hepatocellular carcinoma.代谢功能障碍相关脂肪性肝病及相关肝细胞癌中的肠道微生物群
Nat Rev Gastroenterol Hepatol. 2025 Jul 7. doi: 10.1038/s41575-025-01089-1.
4
NLRP3 Inflammasome Activation in Liver Disorders: From Molecular Pathways to Therapeutic Strategies.肝脏疾病中的NLRP3炎性小体激活:从分子途径到治疗策略
J Inflamm Res. 2025 Jun 24;18:8277-8294. doi: 10.2147/JIR.S532908. eCollection 2025.
5
High uric acid exacerbates nonalcoholic steatohepatitis through NLRP3 inflammasome and gasdermin D-mediated pyroptosis.高尿酸通过NLRP3炎性小体和gasdermin D介导的细胞焦亡加重非酒精性脂肪性肝炎。
J Biol Chem. 2025 May 19;301(6):110249. doi: 10.1016/j.jbc.2025.110249.
6
Biochemical and hematological reference intervals in rhesus and cynomolgus macaques and implications for vaccine and drug development.恒河猴和食蟹猴的生化及血液学参考区间及其对疫苗和药物开发的意义。
Lab Anim (NY). 2025 May 16. doi: 10.1038/s41684-025-01547-y.
7
Dehydrotrametenolic acid methyl ester, a triterpenoid of Poria cocos, alleviates non-alcoholic steatohepatitis by suppressing NLRP3 inflammasome activation via targeting Caspase-1 in mice.茯苓三萜酸甲酯是茯苓中的一种三萜类化合物,通过靶向小鼠中的半胱天冬酶-1抑制NLRP3炎性小体激活,从而减轻非酒精性脂肪性肝炎。
Acta Pharmacol Sin. 2025 May 6. doi: 10.1038/s41401-025-01569-9.
8
Network Pharmacology and Experimental Validation of the Effects of Shenling Baizhu San, Quzhi Ruangan Fang and Gexia Zhuyu Tang on the Intestinal Flora of Rats with NAFLD.参苓白术散、祛脂软肝方和膈下逐瘀汤对非酒精性脂肪性肝病大鼠肠道菌群影响的网络药理学及实验验证
Diabetes Metab Syndr Obes. 2025 Apr 17;18:1165-1194. doi: 10.2147/DMSO.S507039. eCollection 2025.
9
Heterogeneous population of macrophages in the development of non-alcoholic fatty liver disease.非酒精性脂肪性肝病发展过程中巨噬细胞的异质性群体
Liver Res. 2022 Jul 1;7(1):16-25. doi: 10.1016/j.livres.2022.06.001. eCollection 2023 Mar.
10
NLRP3 inflammasome in health and disease (Review).健康与疾病中的NLRP3炎性小体(综述)
Int J Mol Med. 2025 Mar;55(3). doi: 10.3892/ijmm.2025.5489. Epub 2025 Jan 24.

本文引用的文献

1
Animal models of non-alcoholic steatohepatitis: of mice and man.非酒精性脂肪性肝炎的动物模型:鼠与人。
Dig Dis. 2010;28(1):247-54. doi: 10.1159/000282097. Epub 2010 May 7.
2
Non-alcoholic steatohepatitis pathogenesis: role of repair in regulating the disease progression.非酒精性脂肪性肝炎发病机制:修复在调节疾病进展中的作用。
Dig Dis. 2010;28(1):225-8. doi: 10.1159/000282092. Epub 2010 May 7.
3
Nontriglyceride hepatic lipotoxicity: the new paradigm for the pathogenesis of NASH.非甘油三酯性肝脂肪毒性:非酒精性脂肪性肝炎发病机制的新范式。
Curr Gastroenterol Rep. 2010 Feb;12(1):49-56. doi: 10.1007/s11894-009-0083-6.
4
Mechanisms and clinical implications of hepatocyte lipoapoptosis.肝细胞脂肪性凋亡的机制及临床意义
Clin Lipidol. 2010 Feb 1;5(1):71-85. doi: 10.2217/clp.09.85.
5
Nonalcoholic fatty liver disease: pathology and pathogenesis.非酒精性脂肪性肝病:病理学与发病机制。
Annu Rev Pathol. 2010;5:145-71. doi: 10.1146/annurev-pathol-121808-102132.
6
The plasma lipidomic signature of nonalcoholic steatohepatitis.非酒精性脂肪性肝炎的血浆脂质组学特征
Hepatology. 2009 Dec;50(6):1827-38. doi: 10.1002/hep.23229.
7
Toll-like receptor 4 is a key mediator of murine steatotic liver warm ischemia/reperfusion injury.Toll样受体4是小鼠脂肪性肝热缺血/再灌注损伤的关键介质。
Liver Transpl. 2009 Sep;15(9):1101-9. doi: 10.1002/lt.21782.
8
Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.泛半胱天冬酶抑制剂VX-166可减轻非酒精性脂肪性肝炎动物模型中的纤维化。
Hepatology. 2009 Nov;50(5):1421-30. doi: 10.1002/hep.23167.
9
Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal.非酒精性脂肪性肝病中的脂毒性:并非所有脂质都是相同的。
Expert Rev Gastroenterol Hepatol. 2009 Aug;3(4):445-51. doi: 10.1586/egh.09.32.
10
High fat feeding induces hepatic fatty acid elongation in mice.高脂喂养诱导小鼠肝脏脂肪酸延长。
PLoS One. 2009 Jun 26;4(6):e6066. doi: 10.1371/journal.pone.0006066.